Publications

BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies.

Black, GF; Weir, RE; FLOYD, S; Bliss, L; Warndorff, DK; CRAMPIN, AC; Ngwira, B; Sichali, L; Nazareth, B; Blackwell, JM; BRANSON, K; Chaguluka, SD; Donovan, L; Jarman, E; KING, E; FINE, PE M; DOCKRELL, HM;

2002

Lancet, (2002).359 9315 10.1016/S0140-6736(02)08353-8.

Chlamydial heat-shock protein-60 antibody and correlation with Chlamydia pneumoniae in atherosclerotic plaques.

Fong, IW; Chiu, B; Viira, E; Tucker, W; Wood, H; PEELING, RW;

2002

The Journal of infectious diseases, (2002).186 10 10.1086/344730.

Virology. Poliomyelitis eradication--a dangerous endgame.

Nathanson, N; FINE, P;

2002

Science (New York, NY), (2002).296 5566 10.1126/science.1071207.

Validation of immunoglobulin G enzyme-linked immunosorbent assay for antibodies to pneumococcal surface adhesin A in the diagnosis of pneumococcal pneumonia among adults in Kenya.

SCOTT, JA G; Obiero, J; Hall, AJ; Marsh, K;

2002

The Journal of infectious diseases, (2002).186 2 10.1086/341205.

Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales.

Trotter, CL; EDMUNDS, WJ;

2002

BMJ, (2002).324 7341 10.1136/bmj.324.7341.809.

Evaluation of the SPf66 vaccine for malaria control when delivered through the EPI scheme in Tanzania.

Acosta, CJ; Galindo, CM; SCHELLENBERG, D; Aponte, JJ; Kahigwa, E; Urassa, H; SCHELLENBERG, JR; Masanja, H; HAYES, R; Kitua, AY; Lwilla, F; Mshinda, H; Menendez, C; Tanner, M; Alonso, PL;

2002

Tropical medicine & international health : TM & IH, (2002).4 5 10.1046/j.1365-3156.1999.00406.x.

Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study.

Taylor, B; MILLER, E; Lingam, R; Andrews, N; Simmons, A; Stowe, J;

2002

BMJ (Clinical research ed), (2002).324 7334 10.1136/bmj.324.7334.393.

Safety in infants of SPf66, a synthetic malaria vaccine, delivered alongside the EPI.

SCHELLENBERG, DM; Acosta, CJ; Galindo, CM; Kahigwa, E; Urassa, H; Masanja, H; Aponte, JJ; SCHELLENBERG, JR; Fraser-Hurt, N; Lwilla, F; Menendez, C; Mshinda, H; Tanner, M; Alonso, PL;

2002

Tropical medicine & international health : TM & IH, (2002).4 5 10.1046/j.1365-3156.1999.00424.x.

GAVI, the first steps: lessons for the Global Fund.

Brugha, R; Starling, M; WALT, G;

2002

Lancet, (2002).359 9304 10.1016/S0140-6736(02)07607-9.

Immune responses to Plasmodium falciparum antigens during a malaria vaccine trial in Tanzanian children.

Alonso, PL; Lopez, MC; Bordmann, G; Smith, TA; Aponte, JJ; Weiss, NA; Urassa, H; Armstrong-Schellenberg, JR; Kitua, AY; Masanja, H; Thomas, MC; Oettli, A; Hurt, N; HAYES, R; Kilama, WL; Tanner, M;

2002

Parasite immunology, (2002).20 2 10.1046/j.1365-3024.1998.00125.x.